PIN1 was shown to be overexpressed in tamoxifen-resistant breast cancer MCF-7 cells, which have undergone EMT, while PIN1-siRNA treatments downregulated the expression of mesenchymal markers and Snail [185]. This evidence concerns the gene PIN1 and breast cancer.